Hangzhou DALTON BioSciences, Ltd.
Dalton BioSciences (“DALTONbio”) is a global medical technology company focusing on in vitro diagnosis in women’s health, oncology, and infectious diseases. Through investing in cutting-edge technologies and molecular biology, DALTONbio has established leading positions in the clinical diagnosis, screening of cervical cancer and endometrial carcinoma. We are committed to people’s health, particularly women’s well-being, through investing in our business, science & technology for the world.